BAY-794620

N/A

Report date: 2024/02/05 13:54:42

Base Information

Drug NameBAY-794620

Drug Alias Name3ee9-ICMN-ICCA9-ADCCarboanhydrase 9 – antibody drug conjugateBAY-79-4620

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionTubulin inhibitorsTubulin polymerisation inhibitorsMitosis inhibitors +[5]

TargetsCarbonic anhydrase IX

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesNetherlands

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A